Found: 2
Select item for more details and to access through your institution.
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 6, p. 885, doi. 10.1093/jnci/djae062
- By:
- Publication type:
- Article
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 1, p. 53, doi. 10.1002/pbc.24679
- By:
- Publication type:
- Article